Ascend Capital’s Nightstar Therapeutics NITE Stock Holding History
Bought
Maintained
Sold
Other funds holding NITE
Ascend Capital's NITE Position: Q3 2018 in Review
Ascend Capital sold out of Nightstar Therapeutics (NITE) in Q3 2018, closing a stake of 151,691 shares — an estimated $2.43M sold.
Ascend Capital first reported a position in NITE in Q1 2018 and held it in 2 quarters. The position peaked at $2.43M in Q2 2018. 36 funds tracked by Wall St. Rank hold NITE as of Q3 2018.
- Ascend Capital reported no remaining Nightstar Therapeutics position as of Q3 2018 after selling out during the quarter.
- Ascend Capital sold 151,691 Nightstar Therapeutics shares in Q3 2018, an estimated $2.43M.
- Ascend Capital first reported a position in Nightstar Therapeutics in Q1 2018 and held it in 2 quarters.
- Ascend Capital's Nightstar Therapeutics position peaked at $2.43M in Q2 2018.
- 36 funds tracked by Wall St. Rank held Nightstar Therapeutics as of Q3 2018.
Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.